Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Breast Cancer Congress 2022

Challenges and landscape of emerging approaches in metastatic triple negative breast cancer (mTNBC)

Immune biomarkers in mTNBC: Current and emerging

Date

04 May 2022

Session

Challenges and landscape of emerging approaches in metastatic triple negative breast cancer (mTNBC)

Topics

Immunotherapy

Tumour Site

Breast Cancer

Presenters

Roberto Salgado

Authors

R.F. Salgado

Author affiliations

  • GZA Ziekenhuizen Campus Sint-Augustinus, Wilrijk/BE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Updates in metastatic TNBC: Immunotherapy

Presenter: Sherene Loi

Session: Challenges and landscape of emerging approaches in metastatic triple negative breast cancer (mTNBC)

Resources:

Slides

Webcast

New therapies on the horizon for mTNBC

Presenter: Sibylle Loibl

Session: Challenges and landscape of emerging approaches in metastatic triple negative breast cancer (mTNBC)

Resources:

Slides

Webcast

Q&A

Presenter: All Speakers

Session: Challenges and landscape of emerging approaches in metastatic triple negative breast cancer (mTNBC)

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.